Enclomiphene 25mg

Enclomiphene (25mg) is a specialized research reagent utilized primarily to investigate the regulation of the hypothalamic-pituitary-gonadal (HPG) axis and the selective modulation of estrogen receptors. As the purified trans-isomer of clomiphene citrate, it is a potent Selective Estrogen Receptor Modulator (SERM) with distinct antagonistic properties. Dragon Pharma provides Enclomiphene 25mg at a purity level of 99%+, specifically for use in in-vitro laboratory experiments and preclinical animal models.

Overview

In the realm of reproductive endocrinology and hormonal signaling, Enclomiphene has become a fundamental tool for investigators exploring the restoration of endogenous testosterone production. Unlike the racemic mixture of clomiphene, which contains the estrogenic isomer zuclomiphene, Enclomiphene acts almost exclusively as an estrogen receptor antagonist. Dragon Pharma provides Enclomiphene 25mg at a minimum purity of 99%, ensuring that researchers have access to a high-grade Research Compound capable of producing reproducible and accurate data in complex endocrine models.

As scientific inquiry into secondary hypogonadism, spermatogenesis, and metabolic bone health expands, the need for pure SERMs like Enclomiphene has grown. This expanded profile examines the biochemical characteristics, structural integrity, and multifaceted research applications of Enclomiphene 25mg.

Molecular Characteristics and Chemical Profile

The structural integrity of Enclomiphene is what allows it to bind to estrogen receptors in the hypothalamus and pituitary gland. By blocking the negative feedback of estrogen, it prompts the up-regulation of gonadotropin signaling.

• Chemical Identity: Enclomiphene Citrate (trans-clomiphene)
• Molecular Formula: $C_{26}H_{28}ClNO \cdot C_{6}H_{8}O_{7}$
• Molecular Weight: 598.1 g/mol (as citrate salt)
• Purity: >99% (HPLC and Mass Spectrometry verified)
• Form: Crystalline powder / Lyophilized powder
• Manufacturer: Dragon Pharma

Research Applications

The compound is utilized in various scientific investigative domains, including:

• HPG Axis Regulation: Mapping the stimulation of LH and FSH secretion.
• Spermatogenesis: Investigating the improvement of germ cell production and sperm concentration.
• Endocrine Signaling: Studying the selective antagonism of estrogen receptors in the central nervous system.
• Metabolic Bone Research: Assessing the impact of estrogen receptor modulation on bone mineral density.
• Lipid Metabolism: Evaluating the downstream effects of altered androgen-to-estrogen ratios on lipid profiles.

Pathway and Mechanistic Context

The core value of Enclomiphene 25mg in a laboratory setting is its ability to manipulate the Gonadotropin-Releasing Hormone (GnRH) pathway without the suppressive side effects of exogenous androgens. In a natural physiological state, estrogen provides negative feedback to the hypothalamus, limiting the release of GnRH.

The Hypothalamic-Pituitary-Gonadal Axis

Upon antagonism by Enclomiphene, the energy and frequency of GnRH pulses increase. This initiates a global shift in endocrine behavior, promoting the secretion of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) from the anterior pituitary.

Key Mechanistic Shifts:

• Endogenous Testosterone Stimulation: Enclomiphene facilitates the natural production of testosterone by stimulating the Leydig cells in the testes via increased LH.
• FSH Up-regulation: It enhances the signaling to Sertoli cells, providing a framework for studying the chemical induction of spermatogenesis.
• Feedback Loop Resetting: Researchers use Enclomiphene to observe how the HPG axis recovers from perceived suppressive insults, such as those found in models of obesity or metabolic syndrome.

Primary Research Applications

1. Reproductive Endocrinology and Hypogonadism Research

Enclomiphene is heavily utilized in studies involving secondary hypogonadism. Research indicates that low testosterone affects millions of men; in the U.S., the prevalence of hypogonadism is estimated at approximately 19.7% in men over age 30. Studies looking at demographics show varying baseline levels, with some data suggesting that while total testosterone levels may be similar across groups, Caucasian men may have slightly higher sex hormone-binding globulin (SHBG) levels compared to African American men, potentially affecting free testosterone availability. Enclomiphene provides a unique framework for investigating the restoration of the HPG axis in these varied models.

2. Fertility and Spermatogenesis Adaptation

Known in research circles for its "pro-fertility" potential, Enclomiphene is used to observe how tissues adapt to increased gonadotropin levels. Investigators study changes in the microenvironment of the testes and the maturation of germ cells in preclinical models. Unlike traditional TRT, which can cause a 90% reduction in sperm count, Enclomiphene is studied for its ability to maintain spermatogenesis.

3. Oncology and Selective Estrogen Signaling

In oncology research, Enclomiphene is studied for its "anti-estrogenic" effects in various cell lines. Research models focusing on estrogen-sensitive tissues examine how Enclomiphene engages different coregulators compared to other SERMs like Tamoxifen.

Form and Analytical Testing

At Dragon Pharma, the commitment to scientific accuracy begins with a rigorous manufacturing process. Enclomiphene 25mg is produced under strict laboratory conditions to ensure the compound remains stable and potent.

• Stability and Purity: The compound is optimized for long-term stability, removing moisture while preserving the molecular structure critical for maintaining its antagonistic profile.
• Rigorous Analytical Verification: To guarantee a purity level of 99% or higher, every batch undergoes High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) to confirm that the chemical signature matches the verified Enclomiphene profile.